Price
Financials
Standalone, Rs crore| Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.02 | 0.01 | 0.03 | 0.02 | 0.02 | 0.04 | 0.00 | 0.01 | 0.02 | 0.00 | 0.01 | 0.01 |
| Operating Profit | -0.02 | -0.01 | -0.03 | -0.02 | -0.02 | -0.04 | 0.00 | -0.01 | -0.02 | 0.00 | -0.01 | -0.01 |
| OPM % | ||||||||||||
| Other Income | 0.01 | 0.00 | 0.01 | 0.01 | 0.04 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.01 | -0.01 | -0.02 | -0.01 | 0.02 | -0.03 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||
| Net Profit | -0.01 | -0.01 | -0.02 | -0.01 | 0.02 | -0.03 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS in Rs | -0.02 | -0.02 | -0.05 | -0.02 | 0.05 | -0.07 | 0.00 | 0.00 | -0.02 | 0.00 | -0.02 | -0.02 |
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.28 | 0.31 | 0.27 | 1.24 | 0.57 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Expenses | 0.58 | 0.54 | 0.44 | 1.23 | 0.57 | 0.02 | 0.04 | 0.06 | 0.08 | 0.07 | 0.07 | 0.04 |
| Operating Profit | -0.30 | -0.23 | -0.17 | 0.01 | 0.00 | -0.02 | -0.04 | -0.06 | -0.08 | -0.08 | -0.08 | -0.04 |
| OPM % | -107.14% | -74.19% | -62.96% | 0.81% | 0.00% | |||||||
| Other Income | 0.24 | 0.08 | 0.02 | 0.01 | 0.29 | -0.01 | 0.02 | 0.03 | 0.05 | 0.04 | 0.04 | 0.01 |
| Interest | 0.05 | 0.01 | 0.00 | 0.08 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.11 | 0.10 | 0.08 | 0.08 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.22 | -0.26 | -0.23 | -0.14 | 0.27 | -0.04 | -0.02 | -0.03 | -0.03 | -0.04 | -0.04 | -0.03 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 125.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | -0.22 | -0.26 | -0.23 | -0.14 | 0.27 | -0.10 | -0.02 | -0.03 | -0.03 | -0.04 | -0.04 | -0.03 |
| EPS in Rs | -0.53 | -0.63 | -0.56 | -0.34 | 0.65 | -0.24 | -0.05 | -0.07 | -0.07 | -0.10 | -0.10 | -0.06 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | % | % | 0% | ||
| Compounded Profit Growth | 7% | 10% | -13% | -200% | ||
| Stock Price CAGR | -3% | % | % | % | ||
| Return on Equity | -4% | -2% | -2% | -2% |
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 |
| Reserves | -1.04 | -1.26 | -1.52 | -2.01 | -2.12 | -1.87 | -1.97 | -1.99 | -2.02 | -2.05 | -2.09 | -2.13 |
| Borrowings | 0.74 | 0.34 | 0.21 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.16 | 0.03 | 0.19 | 0.25 | 1.12 | 0.00 | 0.02 | 0.01 | 0.01 | 0.03 | 0.02 | 0.04 |
| Total Liabilities | 3.98 | 3.23 | 3.00 | 2.60 | 3.12 | 2.25 | 2.17 | 2.14 | 2.11 | 2.10 | 2.05 | 2.03 |
| Fixed Assets | 2.29 | 2.19 | 2.09 | 1.63 | 1.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.37 | 0.06 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 1.32 | 0.98 | 0.87 | 0.93 | 1.53 | 2.25 | 2.17 | 2.14 | 2.11 | 2.10 | 2.05 | 2.03 |
| Total Assets | 3.98 | 3.23 | 3.00 | 2.60 | 3.12 | 2.25 | 2.17 | 2.14 | 2.11 | 2.10 | 2.05 | 2.03 |
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -0.08 | 0.01 | 0.01 | -0.12 | 0.41 | -1.75 | -0.06 | 0.12 | 0.31 | 0.00 | -0.04 | 0.02 |
| Cash from Investing Activity | -0.05 | 0.43 | 0.02 | 0.00 | 0.07 | 1.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activity | 0.13 | -0.44 | -0.03 | 0.15 | -0.32 | -0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash Flow | 0.00 | 0.00 | 0.00 | 0.03 | 0.16 | -0.03 | -0.06 | 0.12 | 0.31 | 0.00 | -0.04 | 0.02 |
| Free Cash Flow | -0.38 | 0.00 | 0.01 | -0.12 | 0.38 | -0.21 | -0.06 | 0.12 | 0.31 | 0.00 | -0.04 | 0.02 |
| CFO/OP | 50% | -3% | -4% | 71% | 4,100% | 50% | -300% | -517% | 0% | 50% | -25% |
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 462.93 | 495.36 | 259.03 | 270.37 | 332.62 | 1,331.93 | -56,940.00 | -56,940.00 | ||||
| Inventory Days | 812.95 | 1,460.00 | 919.80 | 1,460.00 | 65.05 | 0.00 | 0.00 | 0.00 | ||||
| Days Payable | 265.45 | 73.00 | 102.20 | 279.12 | 350.54 | |||||||
| Cash Conversion Cycle | 1,010.43 | 1,882.36 | 1,076.63 | 1,451.25 | 47.13 | 1,331.93 | -56,940.00 | -56,940.00 | ||||
| Working Capital Days | 1,023.78 | 1,238.39 | 918.39 | 1,013.89 | 97.14 | 1,331.93 | 56,940.00 | 57,305.00 | ||||
| ROCE % | -6.44% | -7.98% | -8.32% | -8.91% | -2.76% | -0.94% | -0.45% | -0.93% | -1.42% | -1.44% | -1.95% | -1.99% |
| Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 37.20% | 37.20% | 37.20% | 37.20% | 37.20% | 37.20% | 37.20% | 37.20% | 37.20% | 37.20% | 37.20% |
| DIIs | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
| Public | 62.69% | 62.69% | 62.69% | 62.69% | 62.69% | 62.69% | 62.69% | 62.69% | 62.69% | 62.69% | 62.69% |
| No. of Shareholders | 9,266 | 9,257 | 9,257 | 9,251 | 9,244 | 9,243 | 9,234 | 9,225 | 9,224 | 9,224 | 9,225 |
Fundamentals
Market Cap₹ 0.21 Cr.
Current Price₹ 0.51
Book Value₹ 4.82
ROCE-1.99 %
ROE-1.99 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)0%
Compounded Profit Growth (TTM)-200%
Standalone figures.
Valuation
P/B, 3-year average0.17x
P/B, 5-year average0.28x
Profitability
Operating margin (excl. other income)800.00%
Operating margin (incl. other income)400.00%
EBITDA margin400.00%
Pre-tax margin400.00%
Net profit margin400.00%
ROE-1.99%
ROCE-1.99%
ROA-1.96%
ROE, 3-year average-1.79%
ROCE, 3-year average-1.79%
ROA, 3-year average-1.77%
ROE, 5-year average-1.55%
ROCE, 5-year average-1.55%
ROA, 5-year average-1.53%
ROIC (approx.)-2.56%
Other income / net worth2.01%
Growth
Sales growth (latest year)0.00%
Per share
EPS (TTM)Rs -0.10
EPS (latest year)Rs -0.10
EPS (latest quarter)Rs -0.02
EPS, 3-year averageRs -0.09
EPS, 5-year averageRs -0.08
Book value per shareRs 4.82
Sales per shareRs -0.02
Cash flow per shareRs 0.05
Free cash flow per shareRs 0.05
Efficiency
Asset turnover-0.00x
Debtor days-56940 days
Debtors turnover-0.01x
Creditor days351 days
Cash conversion cycle-56940 days
Working capital days57305 days
Leverage
Cash and bankRs 0 Cr
Net debtRs -0 Cr
Owners' fund to total sources98.03%
Cash flow
Cash from Operating Activity (latest year)Rs 0 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs 0 Cr
Sales to cash flow-0.50x
Statement figures
Net sales (TTM)Rs -0 Cr
Net sales (latest year)Rs -0 Cr
Operating profit excl. other income (latest year)Rs -0 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -0 Cr
PBDT (TTM)Rs -0 Cr
Profit before tax (TTM)Rs -0 Cr
Net profit (TTM)Rs -0 Cr
Net profit (latest year)Rs -0 Cr
Net profit (latest quarter)Rs -0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 0 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 4 Cr
ReservesRs -2 Cr
Shareholders' fundsRs 2 Cr
Total assetsRs 2 Cr
ReceivablesRs 2 Cr
Other liabilitiesRs 0 Cr
Shares outstanding (crore)0.41
Ownership
Promoter holding37.20% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 4 of 7| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Dec 2018Sales ₹0 Cr.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Vardhaman Laboratories Ltd?
Vardhaman Laboratories Ltd (524796) has a market capitalisation of Rs 0.21 Cr. at the close.
What were Vardhaman Laboratories Ltd's latest quarterly results?
In the Dec 2018 quarter, Vardhaman Laboratories Ltd sales was Rs 0 Cr with a net loss of Rs 0 Cr.